RY 136.23 1.1208% TD 82.27 1.5178% SHOP 106.7 0.1502% CNR 178.63 1.0351% ENB 48.81 0.8888% CP 120.08 1.2735% BMO 130.77 0.3222% TRI 211.67 0.408% CNQ 102.44 0.392% BN 56.39 1.2024% ATD 77.26 0.1166% CSU 3730.29 -0.3412% BNS 69.42 1.4023% CM 67.9 -0.6584% SU 49.5 0.0202% TRP 53.8 -2.0215% NGT 47.86 3.6155% WCN 233.02 0.8483% MFC 33.43 1.8276% BCE 46.5 1.087%
Harley-Davidson, Inc.
Harley-Davidson, Inc. (NYSE: HOG) is a global leader in heavyweight motorcycles, apparel, parts, and accessories. It sells custom, cruiser, and touring motorcycles and Harley-Davidson parts, accessories, riding gear, clothes, and retail.
Key Highlights
Three-Year Technical Price Chart (as of February 11, 2022; at 3:01 PM ET). Analysis by Kalkine Group
Conclusion: Considering the company's robust growth prospects, solid margins, higher debt, global chip shortage, and other technical indicators, we recommend a "Watch" rating on the stock at the current price of USD 41.43, down 2.70% as of February 11, 2022, at 3:01 PM ET.
*The reference data in this report has been partly sourced from REFINITIV.
Hepion Pharmaceuticals, Inc.
Hepion Pharmaceuticals, Inc. (NASDAQ: HEPA) is a biopharmaceutical firm specializing in developing pharmacological therapy for chronic liver illnesses. CRV431, a cyclophilin inhibitor, is being developed by the company to help treat these numerous complicated diseases.
Key Highlights:
Three-Year Technical Price Chart (as of February 11, 2022; 3:05 PM ET). Analysis by Kalkine Group
Conclusion: Considering the company's significant losses, positive results from clinical studies, anticipated growth, and other technical indicators, we recommend a "Watch" rating on the stock at the current price of USD 1.02, down 4.67% as of February 11, 2022, at 3:05 PM ET.
*The reference data in this report has been partly sourced from REFINITIV.
Disclaimer
The advice given by Kalkine Canada Advisory Services Inc. and provided on this website is general information only and it does not take into account your investment objectives, financial situation and the particular needs of any particular person. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. The website www.kalkine.ca is published by Kalkine Canada Advisory Services Inc. The link to our Terms & Conditions has been provided please go through them. On the date of publishing this report (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.